Picture of Sirnaomics logo

2257 Sirnaomics News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Sirnaomics Reports Interim Results Of STP705 Phase I Clinical Study

June 5 (Reuters) - Sirnaomics Ltd  2257.HK :
    * SIRNAOMICS REPORTS INTERIM RESULTS OF STP705 PHASE I
CLINICAL
STUDY FOR MEDICAL AESTHETICS TREATMENT IN ADULTS UNDERGOING
ABDOMINOPLASTY
    * SIRNAOMICS: INITIAL RESULTS OF PHASE I TRIAL APPEAR TO
INDICATE
USE OF STP705 IN TREATMENT OF UNWANTED FAT IS SAFE AND SHOW
CLEAR SIGNS OF EFFICACY

Source text for Eikon:  ID:nPn4WbtnMa 
Further company coverage:  2257.HK

Recent news on Sirnaomics

See all news